| Year |
Citation |
Score |
| 2022 |
Benyair R, Eisenberg-Lerner A, Merbl Y. Maintaining Golgi Homeostasis: A Balancing Act of Two Proteolytic Pathways. Cells. 11. PMID 35269404 DOI: 10.3390/cells11050780 |
0.324 |
|
| 2021 |
Ulman A, Levin T, Dassa B, Javitt A, Kacen A, Shmueli MD, Eisenberg-Lerner A, Sheban D, Fishllevich S, Levy ED, Merbl Y. Altered protein abundance and localization inferred from sites of alternative modification by ubiquitin and SUMO. Journal of Molecular Biology. 167219. PMID 34464654 DOI: 10.1016/j.jmb.2021.167219 |
0.345 |
|
| 2020 |
Marmor-Kollet H, Siany A, Kedersha N, Knafo N, Rivkin N, Danino YM, Moens TG, Olender T, Sheban D, Cohen N, Dadosh T, Addadi Y, Ravid R, Eitan C, Toth Cohen B, ... ... Merbl Y, et al. Spatiotemporal Proteomic Analysis of Stress Granule Disassembly Using APEX Reveals Regulation by SUMOylation and Links to ALS Pathogenesis. Molecular Cell. PMID 33217318 DOI: 10.1016/j.molcel.2020.10.032 |
0.306 |
|
| 2020 |
Eisenberg-Lerner A, Benyair R, Hizkiahou N, Nudel N, Maor R, Kramer MP, Shmueli MD, Zigdon I, Cherniavsky Lev M, Ulman A, Sagiv JY, Dayan M, Dassa B, Rosenwald M, Shachar I, ... ... Merbl Y, et al. Golgi organization is regulated by proteasomal degradation. Nature Communications. 11: 409. PMID 31964869 DOI: 10.1038/S41467-019-14038-9 |
0.328 |
|
| 2019 |
Reznik N, Kozer N, Eisenberg-Lerner A, Barr H, Merbl Y, London N. Phenotypic screen identifies JAK2 as a major regulator of FAT10 expression. Acs Chemical Biology. PMID 31794190 DOI: 10.1021/Acschembio.9B00667 |
0.334 |
|
| 2019 |
Javitt A, Merbl Y. Global views of proteasome-mediated degradation by mass spectrometry. Expert Review of Proteomics. 16: 711-716. PMID 31387416 DOI: 10.1080/14789450.2019.1651979 |
0.338 |
|
| 2019 |
Javitt A, Merbl Y. Global views of proteasome-mediated degradation by mass spectrometry Expert Review of Proteomics. 16: 711-716. PMID 31322460 DOI: 10.1080/14789450.2019.1645601 |
0.436 |
|
| 2019 |
Javitt A, Barnea E, Kramer MP, Wolf-Levy H, Levin Y, Admon A, Merbl Y. Pro-inflammatory Cytokines Alter the Immunopeptidome Landscape by Modulation of HLA-B Expression. Frontiers in Immunology. 10: 141. PMID 30833945 DOI: 10.3389/Fimmu.2019.00141 |
0.343 |
|
| 2018 |
Wolf-Levy H, Javitt A, Eisenberg-Lerner A, Kacen A, Ulman A, Sheban D, Dassa B, Fishbain-Yoskovitz V, Carmona-Rivera C, Kramer MP, Nudel N, Regev I, Zahavi L, Elinger D, Kaplan MJ, ... ... Merbl Y, et al. Revealing the cellular degradome by mass spectrometry analysis of proteasome-cleaved peptides. Nature Biotechnology. PMID 30346940 DOI: 10.1038/Nbt.4279 |
0.376 |
|
| 2018 |
Mor N, Rais Y, Sheban D, Peles S, Aguilera-Castrejon A, Zviran A, Elinger D, Viukov S, Geula S, Krupalnik V, Zerbib M, Chomsky E, Lasman L, Shani T, Bayerl J, ... ... Merbl Y, et al. Neutralizing Gatad2a-Chd4-Mbd3/NuRD Complex Facilitates Deterministic Induction of Naive Pluripotency. Cell Stem Cell. PMID 30122475 DOI: 10.1016/J.Stem.2018.07.004 |
0.336 |
|
| 2017 |
Eisenberg-Lerner A, Regev I, Merbl Y. Post-Translational Modification Profiling-Functional Proteomics for the Analysis of Immune Regulation. Methods in Molecular Biology (Clifton, N.J.). 1647: 139-152. PMID 28809000 DOI: 10.1007/978-1-4939-7201-2_9 |
0.475 |
|
| 2016 |
Eisenberg-Lerner A, Ciechanover A, Merbl Y. Post-translational modification profiling - A novel tool for mapping the protein modification landscape in cancer. Experimental Biology and Medicine (Maywood, N.J.). PMID 27229346 DOI: 10.1177/1535370216651732 |
0.472 |
|
| 2014 |
Merbl Y, Kirschner MW. Post-Translational Modification Profiling-a High-Content Assay for Identifying Protein Modifications in Mammalian Cellular Systems. Current Protocols in Protein Science / Editorial Board, John E. Coligan ... [Et Al.]. 77: 27.8.1-27.8.13. PMID 25081743 DOI: 10.1002/0471140864.Ps2708S77 |
0.576 |
|
| 2014 |
Ortiz-Meoz RF, Merbl Y, Kirschner MW, Walker S. Microarray discovery of new OGT substrates: the medulloblastoma oncogene OTX2 is O-GlcNAcylated. Journal of the American Chemical Society. 136: 4845-8. PMID 24580054 DOI: 10.1021/Ja500451W |
0.508 |
|
| 2013 |
Merbl Y, Refour P, Patel H, Springer M, Kirschner MW. Profiling of ubiquitin-like modifications reveals features of mitotic control. Cell. 152: 1160-72. PMID 23452859 DOI: 10.1016/J.Cell.2013.02.007 |
0.628 |
|
| 2011 |
Merbl Y, Kirschner MW. Protein microarrays for genome-wide posttranslational modification analysis. Wiley Interdisciplinary Reviews. Systems Biology and Medicine. 3: 347-56. PMID 20865779 DOI: 10.1002/Wsbm.120 |
0.573 |
|
| 2010 |
Wu T, Merbl Y, Huo Y, Gallop JL, Tzur A, Kirschner MW. UBE2S drives elongation of K11-linked ubiquitin chains by the anaphase-promoting complex. Proceedings of the National Academy of Sciences of the United States of America. 107: 1355-60. PMID 20080579 DOI: 10.1073/Pnas.0912802107 |
0.494 |
|
| 2009 |
Merbl Y, Kirschner MW. Large-scale detection of ubiquitination substrates using cell extracts and protein microarrays. Proceedings of the National Academy of Sciences of the United States of America. 106: 2543-8. PMID 19181856 DOI: 10.1073/Pnas.0812892106 |
0.587 |
|
| 2008 |
Quintana FJ, Farez MF, Viglietta V, Iglesias AH, Merbl Y, Izquierdo G, Lucas M, Basso AS, Khoury SJ, Lucchinetti CF, Cohen IR, Weiner HL. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 105: 18889-94. PMID 19028871 DOI: 10.1073/Pnas.0806310105 |
0.315 |
|
| 2007 |
Greenbaum L, Strous RD, Kanyas K, Merbl Y, Horowitz A, Karni O, Katz E, Kotler M, Olender T, Deshpande SN, Lancet D, Ben-Asher E, Lerer B. Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication. Pharmacogenetics and Genomics. 17: 519-28. PMID 17558307 DOI: 10.1097/Fpc.0B013E32800Ffbb4 |
0.342 |
|
| 2007 |
Quintana FJ, Merbl Y, Sahar E, Domany E, Cohen IR. Antigen-chip technology for accessing global information about the state of the body. Lupus. 15: 428-30. PMID 16898177 DOI: 10.1191/0961203306Lu2328Oa |
0.316 |
|
| Show low-probability matches. |